Understanding the Transition from Normal Melanocytes to Nevus to Melanoma
Recruiting
Observational Study
Congenital Melanocytic Nevi
Melanoma, Skin
Nevi and Melanomas
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Fundacion Clinic per a la Recerca Biomédica · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary objective of this study is to identify the molecular identity profiles of all cellular states that characterize the progression from benign nevi to malignant melanoma in CAYA patients with L/GCMN. The secondary objectives are:
* To longitudinally characterize the cell-free DNA (cfDNA) from CAYA patients.
* To improve the early diagnosis and treatments for intermediate conditions such …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria:
* Congenital nevus with estimated size of 20 cm
* Be over 18 years of age
Exclusion criteria:
* No available biological material
* Not having signed the informed consent
Contacts